Eterna Therapeutics (ERNA)

• Market cap: $10.9M
• 1 day: -7.91%
• 5 days: -16.88%
• 1 month: 2.4%
• 3 months: -17.42%
• 6 months: -64.35%
• Year to date: -76.9%
• 1 year: -86.12%
• 5 years: -99.89%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Employees: 6